Testosterone supplementation and sexual function: a meta-analysis study.

Introduction: The role of testosterone supplementation (TS) as a treatment for male sexual dysfunction remains questionable.

Aim: The aim of this study was to attempt a meta-analysis on the effect of TS on male sexual function and its synergism with the use of phosphodiesterase type 5 inhibitor (PDE5i).

Methods: An extensive Medline, Embase, and Cochrane search was performed.

Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA).

Introduction: Besides hypogonadism, other endocrine disorders have been associated with male sexual dysfunction (MSD).

Aim: To review the role of the pituitary hormone prolactin (PRL), growth hormone (GH), thyroid hormones, and adrenal androgens in MSD.

Methods: A systematic search of published evidence was performed using Medline (1969 to September 2011).

Standard operating procedures: pubertas tarda/delayed puberty--male.

Introduction: Delayed puberty (DP) is a condition characterized by the lack of sexual maturation in boys (testis volume <4 mL) at a chronological age that is 2.5 standard deviations above the mean age of puberty in a normal population.

Aim: To review the etiology, pathogenesis diagnosis, and the available treatments for DP in males.

Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study.

Objective: To verify whether hypogonadism represents a risk factor for cardiovascular (CV) morbidity and mortality and to verify whether testosterone replacement therapy (TRT) improves CV parameters in subjects with known CV diseases (CVDs).

Design: Meta-analysis.

Methods: An extensive Medline search was performed using the following words 'testosterone, CVD, and males'.